Form 4 for SER Serina Therapeutics, Inc.
Accepted 2025-10-28 00:00:00 ET · period of report 2025-10-27 · accession 0001301120-25-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-28 | 2025-10-27 | SER | Moreadith Randall | CSO | M - OptEx | $0.06 | +949 | 949 | New | +$56.94 |
| D | 2025-10-28 | 2025-10-27 | SER | Moreadith Randall | CSO | S - Sale+OE | $5.19 | -949 | 0 | -100% | -$4,925 |
| D | 2025-10-28 | 2025-10-27 | SER | Moreadith Randall | CSO | M - OptEx | $0.00 | -949 | 409.7K | -0.2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-27 | M | A | 949 | $0.06 | 949 | D | — | — | |
| 2 | Common | Common Stock | 2025-10-27 | S | D | 949 | $5.19 | 0 | D | — | — | (F1) The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.25 to $5.10. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| 3 | Derivative | Stock Option (right to buy) | 2025-10-27 | M | D | 949 | $0.00 | 409,737 | D | $0.06 · — to 2031-05-06 | 949 Common Stock | (F2) The stock options are fully vested. |